GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (OSTO:CANTA) » Definitions » 12-1 Month Momentum %

Cantargia AB (OSTO:CANTA) 12-1 Month Momentum % : -26.43% (As of Jun. 07, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cantargia AB 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-07), Cantargia AB's 12-1 Month Momentum % is -26.43%.

The industry rank for Cantargia AB's 12-1 Month Momentum % or its related term are showing as below:

OSTO:CANTA's 12-1 Month Momentum % is ranked worse than
53.05% of 1476 companies
in the Biotechnology industry
Industry Median: -23.72 vs OSTO:CANTA: -26.43

Competitive Comparison of Cantargia AB's 12-1 Month Momentum %

For the Biotechnology subindustry, Cantargia AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantargia AB's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantargia AB's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Cantargia AB's 12-1 Month Momentum % falls into.



Cantargia AB  (OSTO:CANTA) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantargia AB  (OSTO:CANTA) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Cantargia AB 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Cantargia AB's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantargia AB (OSTO:CANTA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB (OSTO:CANTA) Headlines

No Headlines